SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4xaj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C4D_B_DVAB8_0 (GRAMICIDIN A)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	3 / 3	TRP A 160 VAL A 261 TRP A 342	None None MAL A1900 ( 4.0A)	1.27A	1c4dA-4xajA: undetectable 1c4dB-4xajA: undetectable	1c4dA-4xajA: 2.12 1c4dB-4xajA: 2.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	VAL A 10 VAL A 52 ILE A 62 ASN A 269	None	0.88A	1e06A-4xajA: undetectable	1e06A-4xajA: 13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XZ1_A_HLTA2001_1 (FERRITIN LIGHT CHAIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 4	LEU A 306 SER A 308 TYR A 309 LEU A 292	None	1.16A	1xz1A-4xajA: 2.2	1xz1A-4xajA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XZ3_A_ICFA201_1 (FERRITIN LIGHT CHAIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 4	LEU A 306 SER A 308 TYR A 309 LEU A 292	None	1.17A	1xz3A-4xajA: 2.3	1xz3A-4xajA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C8A_C_NCAC1252_0 (MONO-ADP-RIBOSYLTRAN SFERASE C3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	ARG A1223 SER A1354 ARG A1351 GLU A1264	None	1.25A	2c8aC-4xajA: undetectable	2c8aC-4xajA: 17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CIZ_A_ACTA1320_0 (CHLOROPEROXIDASE)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	ALA A1189 PHE A1226 ILE A1230 VAL A1237	None	0.91A	2cizA-4xajA: undetectable	2cizA-4xajA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J2P_E_SC2E1289_1 (FICOLIN-2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	ASP A 199 THR A 195 LYS A 202 ASP A 360	None	1.24A	2j2pE-4xajA: undetectable 2j2pF-4xajA: undetectable	2j2pE-4xajA: 16.64 2j2pF-4xajA: 16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_D_ASDD1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 9	LEU A1346 LEU A1288 LEU A1228 ALA A1231 PHE A1285	None	1.21A	2vcvD-4xajA: undetectable	2vcvD-4xajA: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 9	LEU A1346 LEU A1288 LEU A1228 ALA A1231 PHE A1285	None	1.26A	2vcvH-4xajA: undetectable	2vcvH-4xajA: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_I_ASDI1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 9	LEU A1346 LEU A1288 LEU A1228 ALA A1231 PHE A1285	None	1.22A	2vcvI-4xajA: undetectable	2vcvI-4xajA: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	PHE A 260 ALA A 164 LEU A 249 PRO A 161	None	0.98A	3bgdA-4xajA: undetectable	3bgdA-4xajA: 18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 7	VAL A 112 GLY A 302 PRO A 231 LYS A 307	None	0.64A	3bjwC-4xajA: undetectable	3bjwC-4xajA: 11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 8	VAL A 112 GLY A 302 PRO A 231 LYS A 307	None	0.84A	3bjwA-4xajA: undetectable	3bjwA-4xajA: 11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	VAL A 345 GLY A 189 ALA A 190 LEU A 194 LEU A 162	None	1.03A	3hs6A-4xajA: undetectable	3hs6A-4xajA: 21.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	10 / 12	ASP A 16 LYS A 17 LYS A 44 GLU A 46 GLU A 47 ALA A 65 ASP A 67 ARG A 68 GLU A 113 TRP A 232	MAL A1900 (-3.2A) MAL A1900 (-2.2A) None MAL A1900 (-3.4A) None MAL A1900 (-3.3A) MAL A1900 (-2.8A) MAL A1900 (-4.1A) MAL A1900 (-2.8A) MAL A1900 ( 4.9A)	0.94A	3jyrA-4xajA: 61.9	3jyrA-4xajA: 58.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	9 / 12	ASP A 16 LYS A 17 LYS A 44 GLU A 47 ALA A 65 ASP A 67 GLU A 113 PRO A 156 TRP A 232	MAL A1900 (-3.2A) MAL A1900 (-2.2A) None None MAL A1900 (-3.3A) MAL A1900 (-2.8A) MAL A1900 (-2.8A) MAL A1900 (-3.4A) MAL A1900 ( 4.9A)	0.47A	3jyrA-4xajA: 61.9	3jyrA-4xajA: 58.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	6 / 7	ASN A 14 TRP A 64 GLU A 155 TYR A 157 MET A 332 TRP A 342	MAL A1900 (-4.6A) MAL A1900 (-4.0A) MAL A1900 (-4.5A) MAL A1900 (-4.2A) MAL A1900 ( 4.5A) MAL A1900 ( 4.0A)	0.31A	3jyrA-4xajA: 61.9	3jyrA-4xajA: 58.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 11	THR A 95 GLN A 327 ALA A 326 ALA A 305 ALA A 303	None	1.14A	3mg0V-4xajA: undetectable 3mg0W-4xajA: undetectable	3mg0V-4xajA: 18.64 3mg0W-4xajA: 16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9C_A_ECLA452_1 (CYTOCHROME P450 164A2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	ALA A1286 LEU A1288 LEU A1347 LEU A1350 LEU A1225	None	1.19A	3r9cA-4xajA: undetectable	3r9cA-4xajA: 22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9C_A_ECLA452_1 (CYTOCHROME P450 164A2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	LEU A1278 LEU A1280 LEU A1288 VAL A1292 LEU A1225	None	0.82A	3r9cA-4xajA: undetectable	3r9cA-4xajA: 22.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	PHE A 158 GLY A 302 LEU A 301 GLU A 113 ALA A 233	None None None MAL A1900 (-2.8A) None	0.84A	3tbgB-4xajA: undetectable	3tbgB-4xajA: 21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	PHE A 158 GLY A 302 LEU A 301 GLU A 113 ALA A 233	None None None MAL A1900 (-2.8A) None	0.82A	3tbgD-4xajA: undetectable	3tbgD-4xajA: 21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VW1_D_CVID301_0 (PUTATIVE REGULATORY PROTEIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	LEU A 292 SER A 308 ILE A 110 ALA A 266 PHE A 87	None	1.27A	3vw1D-4xajA: undetectable	3vw1D-4xajA: 16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 5	GLU A 310 ASP A 316 ASP A 289 ASN A 296	None	1.40A	3vywD-4xajA: undetectable	3vywD-4xajA: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	ALA A1313 ALA A1205 LEU A1209 THR A1208	None	1.06A	4dtzB-4xajA: undetectable	4dtzB-4xajA: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DXU_A_ACAA711_1 (LACTOTRANSFERRIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 6	GLY A 18 VAL A 295 PRO A 300 GLY A 302	None	0.82A	4dxuA-4xajA: 5.8	4dxuA-4xajA: 21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4G19_D_ACTD302_0 (GLUTATHIONE TRANSFERASE GTE1)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	3 / 3	TYR A 169 PHE A1285 ARG A1276	None	1.09A	4g19D-4xajA: undetectable	4g19D-4xajA: 18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	4 / 5	ASN A 269 ALA A 53 GLY A 58 ASP A 16	None None None MAL A1900 (-3.2A)	0.95A	4n48A-4xajA: undetectable	4n48A-4xajA: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 9	ALA A 266 ALA A 107 LEU A 105 LEU A 264 VAL A 263	None	1.13A	4or0B-4xajA: 3.0	4or0B-4xajA: 23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	GLN A 51 ALA A 271 GLY A 56 THR A 55 ALA A 54	None	1.26A	5l66H-4xajA: undetectable 5l66I-4xajA: undetectable	5l66H-4xajA: 16.55 5l66I-4xajA: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	5 / 12	GLN A 51 ALA A 271 GLY A 56 THR A 55 ALA A 54	None	1.26A	5l66V-4xajA: undetectable 5l66W-4xajA: undetectable	5l66V-4xajA: 16.55 5l66W-4xajA: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	6 / 12	ALA A 344 ALA A 340 GLY A 168 ALA A 190 PHE A 171 VAL A 183	None	1.41A	5w4zA-4xajA: undetectable	5w4zA-4xajA: 9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	6 / 12	ALA A 344 ALA A 340 GLY A 168 ALA A 190 PHE A 171 VAL A 183	None	1.45A	5w4zB-4xajA: undetectable	5w4zB-4xajA: 9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	4xaj	MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1 (Escherichia coli; Homo sapiens)	3 / 3	TYR A 157 ASN A 229 LEU A 115	MAL A1900 (-4.2A) None None	0.80A	6b58A-4xajA: 2.6	6b58A-4xajA: 22.73

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C4D_B_DVAB8_0","GRAMICIDIN A","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",3,"TRP A 160;VAL A 261;TRP A 342","None;None;MAL A1900 ( 4.0A)","1.27A","1c4dA-4xajA:undetectable;1c4dB-4xajA:undetectable","1c4dA-4xajA:2.12;1c4dB-4xajA:2.12"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"VAL A  10;VAL A  52;ILE A  62;ASN A 269","None","0.88A","1e06A-4xajA:undetectable","1e06A-4xajA:13.76"],["1XZ1_A_HLTA2001_1","FERRITIN LIGHT CHAIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"LEU A 306;SER A 308;TYR A 309;LEU A 292","None","1.16A","1xz1A-4xajA:2.2","1xz1A-4xajA:14.73"],["1XZ3_A_ICFA201_1","FERRITIN LIGHT CHAIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"LEU A 306;SER A 308;TYR A 309;LEU A 292","None","1.17A","1xz3A-4xajA:2.3","1xz3A-4xajA:14.73"],["2C8A_C_NCAC1252_0","MONO-ADP-RIBOSYLTRANSFERASE C3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"ARG A1223;SER A1354;ARG A1351;GLU A1264","None","1.25A","2c8aC-4xajA:undetectable","2c8aC-4xajA:17.45"],["2CIZ_A_ACTA1320_0","CHLOROPEROXIDASE","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"ALA A1189;PHE A1226;ILE A1230;VAL A1237","None","0.91A","2cizA-4xajA:undetectable","2cizA-4xajA:20.35"],["2J2P_E_SC2E1289_1","FICOLIN-2;FICOLIN-2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"ASP A 199;THR A 195;LYS A 202;ASP A 360","None","1.24A","2j2pE-4xajA:undetectable;2j2pF-4xajA:undetectable","2j2pE-4xajA:16.64;2j2pF-4xajA:16.64"],["2VCV_D_ASDD1224_1","GLUTATHIONE S-TRANSFERASE A3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"LEU A1346;LEU A1288;LEU A1228;ALA A1231;PHE A1285","None","1.21A","2vcvD-4xajA:undetectable","2vcvD-4xajA:18.50"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"LEU A1346;LEU A1288;LEU A1228;ALA A1231;PHE A1285","None","1.26A","2vcvH-4xajA:undetectable","2vcvH-4xajA:18.50"],["2VCV_I_ASDI1224_1","GLUTATHIONE S-TRANSFERASE A3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"LEU A1346;LEU A1288;LEU A1228;ALA A1231;PHE A1285","None","1.22A","2vcvI-4xajA:undetectable","2vcvI-4xajA:18.50"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"PHE A 260;ALA A 164;LEU A 249;PRO A 161","None","0.98A","3bgdA-4xajA:undetectable","3bgdA-4xajA:18.64"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"VAL A 112;GLY A 302;PRO A 231;LYS A 307","None","0.64A","3bjwC-4xajA:undetectable","3bjwC-4xajA:11.46"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"VAL A 112;GLY A 302;PRO A 231;LYS A 307","None","0.84A","3bjwA-4xajA:undetectable","3bjwA-4xajA:11.46"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"VAL A 345;GLY A 189;ALA A 190;LEU A 194;LEU A 162","None","1.03A","3hs6A-4xajA:undetectable","3hs6A-4xajA:21.16"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",10,"ASP A  16;LYS A  17;LYS A  44;GLU A  46;GLU A  47;ALA A  65;ASP A  67;ARG A  68;GLU A 113;TRP A 232","MAL A1900 (-3.2A);MAL A1900 (-2.2A);None;MAL A1900 (-3.4A);None;MAL A1900 (-3.3A);MAL A1900 (-2.8A);MAL A1900 (-4.1A);MAL A1900 (-2.8A);MAL A1900 ( 4.9A)","0.94A","3jyrA-4xajA:61.9","3jyrA-4xajA:58.86"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",9,"ASP A  16;LYS A  17;LYS A  44;GLU A  47;ALA A  65;ASP A  67;GLU A 113;PRO A 156;TRP A 232","MAL A1900 (-3.2A);MAL A1900 (-2.2A);None;None;MAL A1900 (-3.3A);MAL A1900 (-2.8A);MAL A1900 (-2.8A);MAL A1900 (-3.4A);MAL A1900 ( 4.9A)","0.47A","3jyrA-4xajA:61.9","3jyrA-4xajA:58.86"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",6,"ASN A  14;TRP A  64;GLU A 155;TYR A 157;MET A 332;TRP A 342","MAL A1900 (-4.6A);MAL A1900 (-4.0A);MAL A1900 (-4.5A);MAL A1900 (-4.2A);MAL A1900 ( 4.5A);MAL A1900 ( 4.0A)","0.31A","3jyrA-4xajA:61.9","3jyrA-4xajA:58.86"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"THR A  95;GLN A 327;ALA A 326;ALA A 305;ALA A 303","None","1.14A","3mg0V-4xajA:undetectable;3mg0W-4xajA:undetectable","3mg0V-4xajA:18.64;3mg0W-4xajA:16.87"],["3R9C_A_ECLA452_1","CYTOCHROME P450 164A2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"ALA A1286;LEU A1288;LEU A1347;LEU A1350;LEU A1225","None","1.19A","3r9cA-4xajA:undetectable","3r9cA-4xajA:22.79"],["3R9C_A_ECLA452_1","CYTOCHROME P450 164A2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"LEU A1278;LEU A1280;LEU A1288;VAL A1292;LEU A1225","None","0.82A","3r9cA-4xajA:undetectable","3r9cA-4xajA:22.79"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"PHE A 158;GLY A 302;LEU A 301;GLU A 113;ALA A 233","None;None;None;MAL A1900 (-2.8A);None","0.84A","3tbgB-4xajA:undetectable","3tbgB-4xajA:21.79"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"PHE A 158;GLY A 302;LEU A 301;GLU A 113;ALA A 233","None;None;None;MAL A1900 (-2.8A);None","0.82A","3tbgD-4xajA:undetectable","3tbgD-4xajA:21.79"],["3VW1_D_CVID301_0","PUTATIVE REGULATORY PROTEIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"LEU A 292;SER A 308;ILE A 110;ALA A 266;PHE A  87","None","1.27A","3vw1D-4xajA:undetectable","3vw1D-4xajA:16.73"],["3VYW_D_SAMD401_1","MNMC2","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"GLU A 310;ASP A 316;ASP A 289;ASN A 296","None","1.40A","3vywD-4xajA:undetectable","3vywD-4xajA:20.51"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"ALA A1313;ALA A1205;LEU A1209;THR A1208","None","1.06A","4dtzB-4xajA:undetectable","4dtzB-4xajA:22.33"],["4DXU_A_ACAA711_1","LACTOTRANSFERRIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"GLY A  18;VAL A 295;PRO A 300;GLY A 302","None","0.82A","4dxuA-4xajA:5.8","4dxuA-4xajA:21.27"],["4G19_D_ACTD302_0","GLUTATHIONE TRANSFERASE GTE1","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",3,"TYR A 169;PHE A1285;ARG A1276","None","1.09A","4g19D-4xajA:undetectable","4g19D-4xajA:18.78"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",4,"ASN A 269;ALA A  53;GLY A  58;ASP A  16","None;None;None;MAL A1900 (-3.2A)","0.95A","4n48A-4xajA:undetectable","4n48A-4xajA:22.24"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"ALA A 266;ALA A 107;LEU A 105;LEU A 264;VAL A 263","None","1.13A","4or0B-4xajA:3.0","4or0B-4xajA:23.87"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"GLN A  51;ALA A 271;GLY A  56;THR A  55;ALA A  54","None","1.26A","5l66H-4xajA:undetectable;5l66I-4xajA:undetectable","5l66H-4xajA:16.55;5l66I-4xajA:17.04"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",5,"GLN A  51;ALA A 271;GLY A  56;THR A  55;ALA A  54","None","1.26A","5l66V-4xajA:undetectable;5l66W-4xajA:undetectable","5l66V-4xajA:16.55;5l66W-4xajA:17.04"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",6,"ALA A 344;ALA A 340;GLY A 168;ALA A 190;PHE A 171;VAL A 183","None","1.41A","5w4zA-4xajA:undetectable","5w4zA-4xajA:9.03"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",6,"ALA A 344;ALA A 340;GLY A 168;ALA A 190;PHE A 171;VAL A 183","None","1.45A","5w4zB-4xajA:undetectable","5w4zB-4xajA:9.03"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","4xaj","MALTOSE-BINDING PERIPLASMIC PROTEIN,NUCLEAR RECEPTOR SUBFAMILY 2 GROUP E MEMBER 1","Escherichia coli;Homo sapiens",3,"TYR A 157;ASN A 229;LEU A 115","MAL A1900 (-4.2A);None;None","0.80A","6b58A-4xajA:2.6","6b58A-4xajA:22.73"]]